<http://webisa.webdatacommons.org/411221403>	<http://www.w3.org/ns/prov#value>	"The Global Alliance for TB Drug Development (TB Alliance) and the Novartis Institute for Tropical Diseases (NITD) will collaborate to develop new medicines for TB, including drug-resistant strains and faster TB drug regimens that treat all forms of TB, are easier for patients to complete, and can be used safely in patients with HIV/AIDS. 7 July 2008" .
<http://webisa.webdatacommons.org/prov/514343769>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/411221403> .
<http://webisa.webdatacommons.org/411221403>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/411221403>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<mtbeurope.info> .